Login / Signup

Budesonide-formoterol reliever therapy in intermittent versus mild persistent asthma.

Alberto PapiIrene BraithwaiteStefan EbmeierRobert J HancoxTim HarrisonMark HollidayClaire HoughtonLuca MorandiKaren OldfieldIan D PavordHelen K ReddelMathew WilliamsMark WeatherallRichard Beasleynull null
Published in: The European respiratory journal (2021)
Keyphrases
  • chronic obstructive pulmonary disease
  • lung function
  • high intensity
  • stem cells
  • bone marrow
  • mesenchymal stem cells
  • chemotherapy induced